Clinical Trials

Showing 321 - 340 of 513 trials
Titlesort icon Investigator Disease(s)
A Phase III Clinical Trial of Adjuvant Radiation versus Chemoradiation in Patients with Intermediate-Risk, Stage I/IIA Cervical Cancer Treated with Surgery
[Protocol 11-007]
Leitao, Mario
  • Cervical Cancer
A Phase III Comparison of Thoracic Radiotherapy Regimens in Patients with Limited Small Cell Lung Cancer also Receiving Cisplatin and Etoposide
[Protocol 11-003]
Rimner, Andreas
  • Lung Cancer
  • Lung Cancer, Small Cell
    • Other
A Phase III Randomized Study of Concurrent Chemotherapy and Pelvic Radiation Therapy with or without Adjuvant Chemotherapy in High-Risk Patients with Early-Stage Cervical Cancer Following Radical Hysterectomy
[Protocol 10-173]
Leitao, Mario
  • Cervical Cancer
A Phase III Study Assessing Chemoradiation Alone and with Additional Chemotherapy in Women with Locally Advanced, Inoperable Cervical Cancer: The OUTBACK Trial
[Protocol 12-171]
Leitao, Mario
  • Cervical Cancer
A Phase III Study Assessing Radiation Therapy to the Breast/Chest Wall and to the Lymph Nodes in Women Whose Lymph Nodes Were Cleared of Cancer Cells by Chemotherapy Before Surgery
Newly Diagnosed
[Protocol 14-195]
McCormick, Beryl
  • Breast Cancer
A Phase III Study Comparing Different Types of Surgery to Treat Patients with Stage IA Non-Small Cell Lung Cancer
Newly Diagnosed
[Protocol 14-182]
Huang, James
  • Lung Cancer, Non-Small Cell
A Phase III Study Comparing GDC-0199 plus Rituximab with Bendamustine plus Rituximab in Patients with Recurrent or Persistent Chronic Lymphocytic Leukemia
[Protocol 14-215]
Gerecitano, John
  • Leukemia
    • Chronic Lymphocytic Leukemia
A Phase III Study Comparing Gemcitabine plus nab-Paclitaxel to Gemcitabine Alone After Pancreatic Cancer Surgery
[Protocol 14-120]
O'Reilly, Eileen
  • Hepatobiliary
    • Pancreatic Cancer
  • Upper Gastrointestinal
    • Pancreatic Cancer
A Phase III Study Comparing Mometasone Furoate with Eucerin to Treat Radiation-Related Skin Redness and Peeling in Breast Cancer Patients after Mastectomy
[Protocol 13-069]
Olm-Shipman, Molly
  • Breast Cancer
A Phase III Study Comparing Pegylated Interferon Alfa-2a (PEGASYS) with Hydroxyurea in Patients with High-Risk Essential Thrombocythemia or Polycythemia Vera
[Protocol 13-188]
Rampal, Raajit
  • Hematology
    • Hematologic Disorders
A Phase III Study Comparing Standard versus Extended Pelvic Lymph Node Removal During Bladder Cancer Surgery
[Protocol 12-049]
Bochner, Bernard
  • Bladder Cancer
A Phase III Study Comparing Three Different Regimens to Prevent Chronic Graft-versus-Host Disease
[Protocol 14-263]
Perales, Miguel-Angel
  • Blood & Marrow Stem Cell Transplantation
  • Leukemia
A Phase III Study Comparing Two Dosing Schedules for Hypofractionated Image-Guided Radiation Therapy in Patients with Metastatic Cancer
[Protocol 10-154]
Zelefsky, Michael
A Phase III Study Evaluating of the Role of Axillary (Armpit) Lymph Node Removal in Patients with Breast Cancer with Positive Sentinel Lymph Nodes after Preoperative Chemotherapy
Newly Diagnosed
[Protocol 14-151]
King, Tari
  • Breast Cancer
A Phase III Study Evaluating the Addition of Trastuzumab to Standard Therapy for HER2-Positive Esophageal Cancers
[Protocol 12-094]
Wu, Abraham
  • Upper Gastrointestinal
    • Esophageal Cancer
A Phase III Study of Actinomycin-D versus Methotrexate to Treat Low-Risk Gestational Trophoblastic Disease
[Protocol 13-108]
Jewell, Elizabeth
  • Uterine (Endometrial) Cancer
A Phase III Study of AEZS-108 versus Doxorubicin as Second-Line Therapy for Recurrent or Metastatic Endometrial Cancer
[Protocol 13-130]
Konner, Jason
  • Uterine (Endometrial) Cancer
A Phase III Study of Armodafinil versus Placebo to Reduce Cancer-Related Fatigue in Patients with High-Grade Glioma
Newly Diagnosed & Relapsed/Refractory
[Protocol 14-040]
Diamond, Eli
  • Brain Tumors, Primary
    • Gliomas
  • Quality of Life
A Phase III Study of ARN-509 versus Placebo in Men with Non-Metastatic Castration-Resistant Prostate Cancer
[Protocol 13-243]
Rathkopf, Dana
  • Prostate Cancer
    • Rising PSA After Primary Therapy
A Phase III Study of Brentuximab Vedotin plus CHP versus CHOP Therapy for Patients with Previously Untreated CD30-Positive Peripheral T-Cell Lymphoma
[Protocol 13-055]
Horwitz, Steven
  • Lymphoma
    • Non-Hodgkin's Lymphoma